BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 31

• 

  Career Advice

  Scientist as strategist: expanding the role beyond the bench

  Scientists who focus only on generating data risk missing their role in shaping strategy and driving innovation.

  May 13, 2026

   · 

  5 min read

   · 

  Manali Shah
• 

  Mergers & acquisitions

  Mid-sized European drugmakers are snapping up US biotechs. Will the surge continue?

  European pharma companies splashed billions of dollars into the U.S. biopharma sector in a matter of days, but there are differing views on whether the activity represents the rise of a new buyer class or a quirk of timing.

  May 13, 2026

   · 

  4 min read

   · 

  Nick Paul Taylor
• Press Releases

  Nucleus Biologics Launches NB-Lux™ AI, a First-of-its-Kind AI-Enabled, Continuous, Digital Ecosystem That Transforms Media and Buffer Manufacturing and Management from Formula to Finished Product

  May 13, 2026

   · 

  3 min read
• Press Releases

  Zivo Bioscience, Inc. Announces Transition to OTCID Marketplace

  May 13, 2026

   · 

  3 min read
• Press Releases

  Vast Therapeutics to Present Phase 1 Data on First-in-Class Nitric Oxide Therapy ALX1 at the American Thoracic Society 2026 International Conference

  May 13, 2026

   · 

  1 min read
• 

  C-suite

  Lilly, J&J CEOs top pharma’s highest paid list—again

  Three pharma CEOs joined the $30 million compensation club in 2025 but Eli Lilly’s David Ricks exceeded his nearest peer by more than $4 million.

  May 13, 2026

   · 

  5 min read

   · 

  Annalee Armstrong
• Press Releases

  Skylark Bio to Present New Preclinical Data for its Pendrin Gene Therapy Program for Hearing Loss at ASGCT 2026

  May 13, 2026

   · 

  3 min read
• Press Releases

  RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES INTO THE FIRST QUARTER OF 2026 NET REVENUE +4.9%, EBITDA(1) +5.0%, ADJUSTED NET INCOME(2) +7.2%

  May 13, 2026

   · 

  23 min read
• Press Releases

  UPDATE – Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update

  May 13, 2026

   · 

  13 min read
• Press Releases

  Palisade Bio Reports First Quarter 2026 Financial Results and Highlights Continued Clinical Progress of PALI-2108

  May 13, 2026

   · 

  9 min read